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Edited by Stuart FergusonAbstract Based on the Entamoeba histolytica genome project
(www.sanger.ac.uk/Projects/E_histolytica/) we have identiﬁed a
cysteine protease inhibitor, EhICP1 (amoebiasin 1), with signif-
icant homology to chagasin. Recombinant EhICP1 inhibited the
protease activity of papain and that of a trophozoite lysate with
Kis in the picomolar range. By immunocytology, we localized
the endogenous 13 kDa EhICP1 in a ﬁnely dotted subcellular
distribution discrete from the vesicles containing the amoebic
cysteine protease, EhCP1 (amoebapain). In an overlay assay,
we observed binding of recombinant EhICP1 to EhCP1. As a
heptapeptide (GNPTTGF) corresponding to the second
conserved chagasin motif inhibited the protease activity of both
papain (Ki 1.5 lM) and trophozoite extract (Ki in sub-mM
range), it may be a candidate for the rational development of
anti-amoebiasis drugs.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Entamoeba histolytica is the causative agent of amoebiasis,
an infectious disease highly prevalent in developing countries
[1]. The protozoan parasite passes through two life stages,
the vegetative trophozoite and the infective cyst form [2]. Only
the latter is able to survive the harsh conditions of the human
stomach. After excystation in the human gut, the trophozoites
adhere to, and occasionally invade, the intestinal epithelium
(invasive amoebiasis) [3]. E. histolytica is equipped with more
than 20 cysteine protease genes, some of which are presumed
to be involved in diﬀerent aspects of pathogenesis, such as
destruction of host tissue or triggering an inﬂammatory re-
sponse of the infected individual [4,5]. Additionally, cysteine
protease activity is needed for intracellular protein turnover
in the course of cellular housekeeping and for degradation pro-
cesses associated with en- and excystation [6]. In other organ-
isms, protease activity is regulated on several levels, extending
from protease gene expression up to the synthesis of protease-q The nucleotide sequence reported in this paper has been deposited in
the NCBI GenBank and is available under Accession No. AJ634054.
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doi:10.1016/j.febslet.2005.01.067inhibiting proteins. So far, nothing is known concerning the
regulation of proteolytic activity in E. histolytica and no pro-
teaceous inhibitors in this parasite have yet been identiﬁed.
In other eukaryotes, most protein inhibitors of cysteine pro-
teases belong to the cystatin superfamily. These comprise the
cystatins, steﬁns and the cystatin domains of the kininogens
[7]. All of them have a predominant b-sheet structure and mask
the active site of the target enzyme by an N-terminal trunk to-
gether with two hairpin loops around conserved sequence mo-
tifs [8]. More recently discovered protein inhibitors of cysteine
proteases diﬀer considerably from the cystatins in their primary
structure. Among these are the thyropins [9], the propeptide re-
gions of cysteine proteases [10] and the chagasin-like inhibitors
ﬁrst discovered in the parasitic protozoon Trypanosoma cruzi
[11]. Genes encoding cysteine protease inhibitors of the chaga-
sin family have been identiﬁed in pro- and eukaryotic genomes
including that of E. histolytica [12], and the corresponding pro-
teins have been identiﬁed in several pathogenic protozoa and
bacteria and shown to inhibit Clan CA, family 1, of cysteine
proteases [13]. These proteins, which have a molecular size
(Mr  12000) similar to that of the cystatins, are distinguished
by three conserved sequence regions, with otherwise only little
conservation among them. How they interact with their target
proteases is still a matter of speculation.
In this paper, we describe the existence, localization and
inhibitory activity of an endogenous cysteine protease inhibi-
tor (ICP1) of E. histolytica. This inhibitor, which is not related
to proteins of the cystatin/steﬁn-family, has homology to the
chagasin-like cysteine protease inhibitors of other eukaryotic
and prokaryotic pathogens.2. Materials and methods
2.1. Cell culture
Trophozoites of the pathogenic E. histolytica isolate HM1:IMSS
were cultured at 36.5 C in TYI-S-33 medium [14]. Cells were har-
vested at the end of the logarithmic growth phase by centrifugation
at 350 · g and washed three times with PBS#8 [15]. For the prepara-
tion of a soluble cell extract, cells were soniﬁed and the homogenate
was centrifuged at 100000 · g in an ultracentrifuge using a ﬁxed angle
rotor.2.2. Cloning
Genomic DNA was isolated from fresh trophozoites using an Elu-
Quick kit (Schleicher&Schuell). Sequencing of icp1was performed after
ampliﬁcation of the complete gene using primers constructed according
to sequence information from the Sanger Entamoeba genome project.
(These sequence data were produced by the E. histolytica Sequencingblished by Elsevier B.V. All rights reserved.
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ger.ac.uk/Projects/E_histolytica/, clone Ent281g09.q1c): 5 0-AATATC-
CATATGTCATTAACTGAAGATAATAAC-3 0 with a restriction site
(shown in bold) forNdeI and 5 0-TCTGGAAAAAGACCTAGGTTAC-
TGGACATTAAC-3 0 with a BamHI restriction site. PCR was
performed on genomic DNA, with Taq-polymerase (Eppendorf). The
thermal cycler (Master cycler personal, Eppendorf) was programmed
as follows: 10 min at 94 C; then 45 cycles with (1 min at 50 C; 1 min
at 72 C; 1 min at 94 C); ending with 2 min at 50 C and 5 min at
72 C. The ampliﬁcation product was puriﬁed with a Qiaprep-spin-kit
(Qiagen) according to the instructions of the manufacturer, cloned into
pBSK and sequenced by automated dideoxy chain termination (MWG
Biotech).
2.3. Heterologous production of recombinant EhICP1
The ampliﬁcation product was digested with BamHI and NdeI and
ligated in frame into the multiple cloning site of the expression vector
pJC45 a derivative of pJC40, which contains a 5 0 extension sequence
coding for 10 histidine residues (His-tag) [16]. Recombinant plasmids
were transformed into Escherichia coli BL21(DE3)pAPlacIQ and bac-
teria were plated on YT agar plates (200 lg/ml ampicillin). Freshly
transformed single colonies were inoculated into YT medium
(200 lg/ml ampicillin) and grown at 37 C until OD600 reached 0.4. Re-
combinant expression was induced by addition of induction with iso-
propyl-1-thio-b-D-galactopyranoside at a ﬁnal concentration of
0.8 mM. Culturing was continued for 3 h. The overproduced protein
product was partially present in the soluble fraction, as checked by
SDS–PAGE. For puriﬁcation, the soluble E. coli extract was adjusted
to 25 mM imidazole, the mixture applied onto a Ni–NTA-column and
the recombinant protein eluted with 20 mM Tris–HCl, pH 7.9, con-
taining 250 mM imidazole. This yielded a >95% pure (judging from
SDS–PAGE) recombinant protein.
2.4. Production of antiserum
The antiserum to EhICP1 was raised in rabbits by repeatedly inject-
ing subcutaneously 100 lg of the puriﬁed recombinant protein. The
antiserum to EhCP1 was raised in a chicken by repeatedly injecting
s.c. 100 lg of puriﬁed recombinant EhCP1. For that purpose EhCP1
was recombinantely expressed in E. coli using the pJC45 expression
vector as described for EhICP1 [17].
2.5. Northern blot analysis
RNA from trophozoites of various isolates was isolated using TRI-
ZOL reagent (Gibco-BRL). For Northern blotting, agarose gels were
loaded with 20 lg total RNA. After transfer to a nylon membrane,
the blots were sequentially hybridized with radiolabeled DNA probes
obtained by PCR on icp1 as described in Section 2.2 and by restriction
digest of E. histolytica actin gene as a loading control. Hybridizations
were performed in 0.5 M Na2HPO4, 7% SDS and 1 mM EDTA (pH
7.2) at 55 C. Blots were washed in 40 mM Na2HPO4 and 1% SDS
(pH 7.2) at 55 C.
2.6. Peptide synthesis
The heptapeptide GNPTTGF was synthesized following the Fmoc
solid-phase strategy [18] on a peptide synthesizer LKB Biolynx 4175
(Amersham–Pharmacia Biotech) and the crude peptide was puriﬁed
by reversed-phase HPLC using a C18-column and a linear gradient
of 0–50% acetonitrile in 0.1% TFA.
2.7. Inhibition of cysteine protease activity
Inhibition of cysteine protease activity was measured by pre-incuba-
tion of papain (test concentration 22 pM) or the trophozoite superna-
tant fraction (test concentration 0.2 lg/ml) with inhibitor (recombinant
EhICP1 or the synthetic peptide GNPTTGF) at diﬀerent dilutions for
30 min at room temperature in 100 mM sodium phosphate, pH 6.0,
containing 2 mM EDTA and 1 mM DTT, and subsequent addition
of Z-Phe-Arg-7-amido-4-methylcoumarin (for papain) or Z-Arg-Arg-
7-amido-4-methylcoumarin (for amebic cell extract) as substrates to
50 lM end concentration each. Initial rates of substrate hydrolysis in
the absence (vo) and presence of inhibitor at various concentrations
(vi) were measured ﬂuorometrically at 380 nm excitation and 440 nm
emission in three independent experiments. Equilibrium dissociation
constants, Ki, were calculated by plotting [I]/(1  vi/vo) versus vo/vi [19].2.8. Far-Western analysis
Recombinant EhICP1 (15 lg) was subjected to SDS–PAGE in a
12.5% SDS-gel [20] and electroblotted onto a nitrocellulose membrane
in 0.1 M Caps-buﬀer, pH 11 [21]. The membrane was incubated for
60 min at room temperature with a trophozoite extract (2.4 mg/ml) di-
luted 1:100 in PBS#8 containing 2 mM EDTA, 1% BSA and 0.05%
Tween 20. After washing for 10 min at room temperature in the same
buﬀer without the extract, the membrane was subjected to an anti-
amoebapain (EhCP1) antibody [22] diluted 1:2000 in NET-buﬀer
(50 mM Tris, 5 mM EDTA, 150 mM NaCl, 0.05% Nonidet P-40,
0.1% BSA and 0.25% gelatine, pH 7.5). Crossreaction was visualized
through incubation with peroxidase-labeled anti-rabbit antiserum
from goat (Pierce, 1:20000) followed by addition of H2O2 and 4-
chloro-1-naphthol as chromogenic substrate.
2.9. Fluorescence microscopy
To compare the localization of EhICP1 and of an amoebic cysteine
protease in trophozoites, 105 freshly harvested and washed cells were
ﬁxed with 3% paraformaldehyde in 0.1 M cacodylate buﬀer, pH 7.5,
and permeabilized with PBS containing 0.2% saponin (PBSS) accord-
ing to the protocol of Leippe et al. [23]. Free aldehyde groups were
blocked by subsequent incubation with 50 mM ammonium chloride
in PBSS. After incubation with blocking buﬀer (2% fetal porcine serum
in PBS) for 10 min, cells were incubated for 1.5 h with both rabbit anti-
EhICP1 antiserum (dilution 1:150 in PBSS) and chicken EhCP1-
antiserum (1:250). Cells were washed three times with PBS for 1 h
and ﬁnally incubated in the dark with (CY3e)-conjugated anti-rabbit
F(ab)2 fragment from sheep (Dianova; 1:1500 in PBS) and (CY2e)-
conjugated anti-chicken antiserum from Dianova (1:1500) at room
temperature. Nuclei were stained with DAPI (1:2000) for 2 min. After
additional three washes with PBS, the cells were analyzed in a ﬂuores-
cence microscope (Axioskop2plus, ZEISS).3. Results
As E. histolytica appears to lack cystatin-like sequences, we
screened the database of the E. histolytica genome project of
the Sanger Institute for open reading frames encoding se-
quences homologous to that of chagasin, a cysteine protease
inhibitor recently discovered in T. cruzi [11]. We identiﬁed an
open reading frame (abbreviated as icp1), which we ampliﬁed
on genomic DNA as a template. The derived amino acid se-
quence (Fig. 1) of the putative inhibitor, which we named
EhICP1, is not identical to that presented in Ref. [12]. It con-
sists of 102 amino acid residues with a calculated molecular
mass of Mr 11123 and a pI of 6.26. Similar to chagasin, the
secondary structure of EhICP1 is predicted to lack a-helices
and to consist mainly of b-strands. As noted by Sanderson et
al., similar sequences are found in all kingdoms of organisms
[13]. According to an alignment of selected sequences using
the CLUSTAL W algorithm, EhICP1 has about 30% sequence
identity to chagasin of T. cruzi and 27% to a cysteine protease
inhibitor sequence of Leishmania mexicana, an even higher
37% to a C-terminal domain of a hypothetical protein from
the archaeonMethanosarcina acetivorans and 22% to an inhib-
itor sequence of the pathogenic eubacterium Pseudomonas
aeruginosa.
To investigate the inhibitory potency of EhICP1 and to
raise polyclonal antibodies against the protein, we overex-
pressed the icp1 sequence heterologously in E. coli and puri-
ﬁed the his-tagged recombinant EhICP1 by Ni-chelate
chromatography. As shown in Fig. 2A, recombinant EhICP1
eﬀectively inhibited the peptidase activity of both papain and
a soluble trophozoite extract, with equilibrium dissociation
constants, Ki, in the picomolar range (15 pM for papain to-
wards Z-Phe-Arg-7-amido-4-methylcoumarin and 3.5 pM
Fig. 3. Expression of icp1 in trophozoites. Total RNA of diﬀerent
E. histolytica strains was separated on formaldehyde–agarose gels,
blotted onto nylon membranes, and hybridized with the icp1 ampli-
ﬁcation product and with E. histolytica actin gene as a control.
A
B
Fig. 1. Alignment of the deduced amino acid sequences of chagasin-like inhibitors. (A) Sequences from E. histolytica (AJ634054), L. mexicana
(AJ548776), T. cruzi (AJ299433), P. aeruginosa (PA0778), horizontal arrows indicate predicted b-sheets. (B) Alignment of the C-termini of the amino
acid sequences of chicken cystatin (P01038), the third domain of rat kininogen T (Q63581) and EhICP1.
Fig. 2. Inhibition of peptidolytic activity. The peptidolytic activity of
trophozoite extract and papain was measured in the presence of
increasing concentratons of recombinant EhICP1 (A) and the synthetic
peptide GNPTTGF (B). The activity without inhibitor was set at
100%. —¤—, activity of papain towards Z-Phe-Arg-AMC; —e—,
activity of trophozoite extract towards Z-Arg-Arg-AMC. The error
bars reﬂect deviations from three independent experiments. For further
experimental details, see Section 2.
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methylcoumarin as substrates).
To analyze whether icp1 is expressed in trophozoites, we
probed a Northern blot with the ampliﬁed icp1 sequence. As
shown in Fig. 3, both HM1:IMSS and other E. histolytica
strains exhibited a positive signal of nearly the same intensity
considering that the amount of RNA in the case of HM-1:IM-
SS(ATCC) was lower as shown in the actin control. To inves-
tigate whether the protein is present in trophozoites, we probed
trophozoite extract with anti-EhICP1 antiserum. To this end,
we exploited the thermal stability of chagasins [11] to enrich
for the protein by boiling a soluble extract for 15 min and dis-
carding the denatured protein fraction. As shown in Fig. 4A,
lane 2, the antiserum recognized a protein of 13 kDa whichwas barely detectable by Coomassie staining (Fig. 4A, lane
1). These data conﬁrm that icp1 is expressed and that EhICP1
is present in the trophozoites. To estimate its concentration in
trophozoite extract, we performed a competitive ELISA with
immobilized recombinant EhICP1. In this test, the amount
of endogenous EhICP1 in the extract turned out to be under
the lower limit of detection, which amounted to less than
0.1% of total soluble protein (data not shown).
To analyze whether recombinant EhICP1 interacts with
amoebapain (EhCP1), a major trophozoite cysteine protease
[22], we performed a ligand-blotting assay in which puriﬁed
recombinant inhibitor was probed with trophozoite extract
Fig. 4. Probing trophozoite extract for the presence of EhICP1 and
EhICP1-binding protease. (A) Detection of endogenous EhICP1 in the
soluble fraction of boiled trophozoite extract (20 lg protein). Lane 1:
Coomassie-stained SDS gel, lane 2: Western blot probed with anti-
EhICP1 (1:1000). (B) Detection of interaction between recombinant
EhICP1 (15 lg) and endogenous amoebapain. Lane 1: SDS gel of
recombinant EhICP1 stained with Coomassie brilliant blue; lane 2:
overlay assay with trophozoite extract and immunodecoration with
anti-amoebapain (EhCP1) antibody.
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incubation without trophozoite extract the anti-amoebapain
antiserum did not show a crossreaction (data not shown),
the outcome of the interaction assay was unambiguously posi-
tive (Fig. 4B, lane 2; as reelectrophoresis of the 14 kDa band
yielded a similar pattern (data not shown), the ladder of bands
at higher molecular masses is due to formation of inhibitor
oligomers).Fig. 5. Schematic drawing of the predicted secondary structures of
cystatin and EhICP1. In both proteins, conserved motifs form loops
that are exposed on one side of the molecule and jointly contact the
target protease.Comparison of the EhICP1 sequence with those of several
hypothetical inhibitors from other organisms (Fig. 1) shows
that these proteins contain three regions with conserved se-
quence elements: LXG/SNPTTGY/FXW at positions 24–34,
GXGG at positions 59–62 and LXYXRPW at positions 80–
86, respectively [12,13]. The ﬁrst motif has, by theoretical con-
siderations and by modeling of the chagasin sequence based on
the IgG structure, been suggested to tightly contact the active
site of the target protease [12]. To test whether this motif is
actually involved in inhibition, we synthesized the heptapep-
tide GNPTTGF and tested it for inhibitory activity towards
papain and towards soluble trophozoite extract. As shown in
Fig. 2B, the peptide strikingly inhibited the proteolytic activity
of papain (Ki 1.5 lM) and, less eﬃciently (presumably due to
peptidolysis), that of the trophozoite extract (Ki 0.2 mM). A
control peptide with the sequence GNATTGF at concentra-
tions up to 1 mM did not inhibit the proteolytic activity. This
both supports the notion that this motif is directly involved in
protease inhibition and identiﬁes proline as a key residue in
inhibition.
To gain ﬁrst insight as to the function of EhICP1 within the
trophozoites, we determined the subcellular localization of the
inhibitor compared to that of the amoebic cysteine protease
EhCP1 by indirect immunoﬂuorescence using ﬁxed and perme-
abilized Entamoeba trophozoites. As can be seen in Fig. 6, the
anti-EhICP1 antibodies recognized a ﬁnely dotted distribution
across the cytoplasma. EhICP1 did not co-localize with the
protease, which predominantly resided in larger vesicular
structures.4. Discussion
In this study, we demonstrate that trophozoites of E. histoly-
tica contain low amounts of a chagasin-like cysteine protease
inhibitor (EhICP1), which we propose to designate as amoe-
biasin 1. As shown in Fig. 6, EhICP1 exhibited a ﬁne dotted
distribution distinct from the vesicles containing the potential
amoebic target proteases. These latter enzymes, like papain,
belong to CLAN A of cysteine proteases. Of the 20 encoding
genes only eight are expressed under culture conditions, with
EhCP1 (amoebapain), EhCP2 (histolysain) and EhCP5 to-
gether contributing >90% of the proteolytic activity of tropho-
zoite extracts [6]. In agreement with the overall distribution
observed for EhICP1 (Fig. 6), the predicted amino acid se-
quence of EhICP1 lacks a classical N-terminal signal sequence,
which implies that most probably it is a cytosolic protein. If so,
it could serve to protect the cytosol against cysteine protease
molecules released by damaged intracellular vesicles. By con-
trast, leishmanial ICP, which does contain a signal sequence
and an extended prodomain, has a vesicular distribution and
is suggested to play a role in the interaction between host
and parasite [24]. Whatever its function, EhICP1 seems to be
present at substoichiometric amounts compared to the endog-
enous cysteine proteases [6].
Amoebiasin 1 is not homologous to the well-characterized
members of the cystatin family [7]. In this inhibitor type,
three segments of the protein contribute to a hydrophobic
wedge into the active site of the protease [8]. In detail,
according to the docking model of cystatin/protease interac-
tion, the catalytic cysteine residue of the protease is sur-
rounded by residues of the amino terminal trunk and two
Fig. 6. Immunocytochemical localization of EhICP1 and amoebic cysteine protease in permeabilized trophozoites. Incubation with anti-EhCP1
antiserum (1:250) and (CY2e)-labeled secondary antibodies (1:1500), green, and anti-EhICP1 antiserum (1:150) and (CY3e)-labeled secondary
antibodies (1:1,500), red. Nuclei were stained with DAPI (1:2000), blue. For further details, see Section 2.
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tor structure [8,25]. The relevance of the second cystatin
hairpin loop, which contains a well conserved Pro-Trp-
doublet, is poorly understood. In this context, we note that
the third conserved motif of EhICP1, LXYXRPW, resembles
the amino acid sequence around the second hairpin loop of
cystatin C-like inhibitors, as well as of the third inhibitor do-
main of rat T-kininogens (Fig. 1B) [8,25,26]. According to
the Ig-model of Rigden et al. for the chagasin structure
[27], the C-terminal RPW-motif in EhICP1 may be embed-
ded in a loop between the two anti-parallel b-strands 7
and 8 (Fig. 1) facing the active site of the target protease.
This leads us to hypothesize that, as in cystatins, three seg-
ments of EhICP1 contact the target protease (Fig. 5). Such
an arrangement would support the hypothesis of a module-
like appearance of cysteine protease inhibitor motifs in a
convergent evolutionary process [12].
In summary, the present report proves the functionality of a
cysteine protease inhibitor of E. histolytica and supports the
hypothesis that the conserved NPTTG motif of the chagasins
contributes to the interaction of the inhibitor protein with
the active site of the target protease. As pre-treatment of tro-
phozoites with the synthetic protease inhibitor E-64 has been
shown to reduce their ability to form liver abscesses in labora-
tory animals [28], this predestines NPTTG-based peptides
as starting points for the rational development of an anti-
amoebic drug [29].
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